Omega Therapeutics Inc (OMGA)
1.12
+0.06
(+6.16%)
USD |
NASDAQ |
Nov 05, 14:34
Omega Therapeutics Profit Margin (Quarterly): -764.1% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -764.1% |
| March 31, 2024 | -852.9% |
| December 31, 2023 | -2.04K% |
| September 30, 2023 | -2.68K% |
| June 30, 2023 | -3.91K% |
| March 31, 2023 | -4.90K% |
| Date | Value |
|---|---|
| December 31, 2022 | -4.19K% |
| September 30, 2022 | -4.34K% |
| June 30, 2022 | -5.44K% |
| March 31, 2022 | -7.52K% |
| December 31, 2021 | -14.48K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-14.48K%
Minimum
Dec 2021
-764.1%
Maximum
Jun 2024
-4.65K%
Average
-4.19K%
Median
Dec 2022
Profit Margin (Quarterly) Benchmarks
| Moderna Inc | -578.7% |
| NovaBay Pharmaceuticals Inc | -66.04% |
| Palatin Technologies Inc | -2.36K% |
| iBio Inc | -4.44K% |
| Theriva Biologics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -132.6% |
| Return on Assets | -39.33% |
| Return on Invested Capital | -100.9% |
| Operating Margin (Quarterly) | -776.9% |
| Return on Net Operating Assets | -65.70% |